Profiles in Pharma - April 2, 2025
The Jalkanens: A shared thirst for knowledge
For Sirpa and Markku Jalkanen of Finland, M.D. and Ph.D., married, immunotherapy researchers, working together came as naturally as a courtship.
Profiles in Science - September 10, 2024
“Rare diseases lead the way in precision medicine”
Anna Wedell, Professor and Research Group Leader of the group Inborn Errors of Endocrinology and Metabolism at Karolinska Institutet and Director of the new Precision Medicine Center Karolinska, explains how research in rare diseases has evolved due to new technologies, and emphasizes that identifying synergies is essential for diagnosing and treating these conditions.
Profiles in Science - July 16, 2024
“I am glad to have contributed direct answers to human biology”
Kirsty Spalding started her career as a neuroscientist and given a succession of casual events, she ended up studying adipose biology.
Profiles in Science - June 24, 2024
Exclusive interview: Jens Juul Holst
His is not a household name, but the drugs developed thanks to Danish scientist Jens Juul Holst’s research certainly are.
Profiles in Science - June 18, 2024
“I would like to push the field of cell therapy forward”
Anna Falk, Head of Lund University’s Center for Advanced Therapies (LU-ATMP) and principal researcher of the Department of Neuroscience at Karolinska Institutet (KI) shares insights into her research, her multi-faceted job, and her vision for the future of neuroscience. Anna Falk is a molecular biologist with a PhD in neural stem cells and adult neurogenesis. […]
Profiles in Science - March 8, 2017
“My basic personality is more like a discoverer”
Sirpa Jalkanen is a professor in the Academy of Finland, board member of Orion, and cofounder of BioTie Therapies and Faron Pharmaceuticals. BioTie Therapies and Faron Pharmaceuticals develop drugs for inflammation and immune-related conditions. In 2016, BioTie was acquired by Acorda Therapeutics. How did you turn basic research findings into companies? “When we returned from […]
